Estimates were made of the proportion of chemicals that were carcinogenic, anticarcinogenic, or either in 397 long-term bioassays conducted by the National Toxicology Program (NTP) (3, 6, 7) .
The National Cancer Institute and, more recently, the National Toxicology Program (NTP) have been routinely testing chemicals for carcinogenic potential in long-term rodent bioassays for about 25 years (1) (2) (3) . Most of the chemicals have been tested in separate groups of animals composed of males and females of two species (generally rats and mice). These bioassays were initially designed to screen for potential human carcinogens, and it was anticipated that further studies would be conducted on the chemicals identified as carcinogenic. Because NTP bioassays involve relatively few animals (generally 50 animals are tested at each of 2 or 3 dose levels, in addition to 50 control animals, in each of the 4 sex-species groups), relatively high doses were used to minimize the possibility that a potential human carcinogen would not be identified (3, 4) . Because of financial and time constraints, followup studies have often not been conducted, and results from NTP bioassays have been used extensively in the regulation of chemicals-not only to identify potential carcinogenic hazards to humans, but also to determine dose-response relationships.
More than 400 chemicals have been tested to date by the NTP, about one-half of which have been identified as carcinogenic in at least one sex-species group (1) (2) (3) . Some researchers have expressed concern at finding such a high percentage of carcinogens and believe that many of these carcinogenic responses are generalized indirect reactions to high-dose toxicity, which consequently may not be relevant to humans exposed to much lower levels (5) . On the other hand, it has been pointed out that most chemicals were selected for testing by the NTP because they were suspected carcinogens and are not necessarily representative of all chemicals in commercial use (3, 6, 7) .
In the current study, we developed independent estimates of the proportions of chemicals that were carcinogenic in each sex-species group, as well as the proportion of chemicals that were carcinogenic in any group, among chemicals tested by the NTP, and compared these estimates to the proportions identified by the NTP. We also estimated the proportions of chemicals that were anticarcinogenic (i.e., caused doserelated decreases in tumor incidence in one or more tumor categories) and the proportions that were either carcinogenic or anticarcinogenic. The NTP did not routinely evaluate chemicals for anticarcinogenesis.
These estimates are based on a substantially different methodology (8) (9) (10) (11) :T The p-value for a test for an effect in any sex-species experiment was defined as 1 -(1 -Pmin)k where Pmin was the minimum pvalue from all sex-species experiments, and k was the number of such experiments in a study (in the majority ofstudies, k = 4).
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cated data rather than to the actual data. Figure 3 shows values of the estimator K(a) of the proportion of carcinogens, with corresponding 90% confidence intervals, as a function of the parameter a. The horizontal line in these graphs represents the proportion of carcinogens based on the NTP classifications ( Table 1 ). Recall that K(a) is negatively biased for all values of a, and this bias decreases with increasing a. However, the variance of K(a) increases with increasing a, which accounts for the fact that confidence intervals in Figure 3 reduce bias, but not so large that the variance was excessively large. Table 2 also shows the proportions of carcinogens identified by the NTP. Our estimates of the proportion of carcinogens in the different sex-species groups were similar, ranging from 0.28 in female mice to 0.35 in male rats. These estimates are also fairly similar to the NTP proportions. Our estimate of the proportion of chemicals that were carcinogenic in any sex-species group was 0.59, which was larger than the NTP proportion of 0.51. However, the NTP value was contained in our 90% confidence interval of 0.49-0.69. Our estimates of the proportion of anticarcinogens in sex-species groups ranged from 0.27 to 0.44 (Table 2) . Except for female mice, these estimates were larger than our corresponding estimates of the proportion of carcinogens. We estimated that 0.66 of the chemicals were anticarcinogenic in at least one sex-species group. (Fig. 1) . We recommend that the NTP consider formally adjusting for multiple comparisons in their statistical analysis, just as we have done. Such an approach would make determinations of statistical significance more easily interpreted and could lead to more equitable classifications of carcinogenic responses across different sex-species groups.
Another factor that may have contributed to our finding a larger proportion of liver carcinogens than the NTP stemmed from the high frequency of dose-related increases among liver tumors and the occurrence of some of these tumors through mechanisms that were of questionable relevance to humans. To compensate, the NTP may have used more stringent criteria for evaluating liver tumors than tumors at other sites.
Although we did not find evidence for larger proportions of carcinogens than were identified by the NTP, there were differences between our findings and those of the NTP for individual chemicals (Table  1) . Based on using a conventional significance level of 0.05 in our analysis, the overall concordance between our analysis and the NTP ranged from 0.91 for male mice to 0.85 for male rats. We were not able to improve this degree of concordance appreciably by using different significance levels for our analysis. There are a number of potential reasons for these differences. Whereas Crump et al. (JI) used the "two-point estimator,"
where a and b are two judiciously chosen points between 0 and 1.0. This estimator reduces to the one-point estimator, K(a), used in the present study when b = 1.0. This refinement was not needed in the present study because, except possibly for female mice, the CDFs do not exhibit an effect of anticarcinogenesis (Fig. 2) Haseman and Johnson (13) concluded that much of the anticarcinogenesis seen in NTP bioassays was indirectly caused by a dose-related reduction in weight gain. This mechanism may not be operative except at very high doses. However, this uncertainty is not limited to this mechanism or even anticarcinogenesis, as there is generally uncertainty regarding whether an effect seen in a high-dose NTP bioassay, either carcinogenic or anticarcinogenic, will occur at lower doses.
This study estimated that 85% of the chemicals studied by the NTP were either carcinogenic or anticarcinogenic at some site in some sex-species group of rodents. It should be kept in mind that the estimator used to obtain this estimate is inherently negatively biased. This suggests that most chemicals, when given at sufficiently high doses, may cause perturbations that affect tumor responses, causing increases at some sites and decreases at others. These effects will undoubtedly be smaller at lower doses, but identification of doses at which they do not occur will be highly problematic.
